RxDoctor Payments Data

Ryan Walters, MD

Family Medicine · Lexington, SCNPI 1992225338

Payments from drug & device makers

$4,193in general payments, 2019–2025

Across 237 payments — averaging $17.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$528
  • AstraZeneca$383
  • Pfizer$375
  • Lilly USA, LLC$330
  • Astellas Pharma US Inc$243
  • Dexcom, Inc.$229
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$4,09898%
  • Education$952%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,193 in reported general payments places this provider in the 80th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$108,735
Medicare patients
245
Services billed
2,009

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide35$65,970
JardianceEmpagliflozin39$55,076
FarxigaDapagliflozin Propanediol44$44,878
OzempicSemaglutide27$36,898
MounjaroTirzepatide23$26,345
Breztri AerosphereBudesonide/Glycopyr/Formoterol23$16,362
EliquisApixaban15$14,986
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$13,413
XareltoRivaroxaban11$11,571
NamzaricMemantine Hcl/Donepezil Hcl11$6,536
Rosuvastatin Calcium298$4,411
SymbicortBudesonide/Formoterol Fumarate14$4,273
SynthroidLevothyroxine Sodium44$4,220
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$4,126
Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med47$3,473

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$330$92,31558 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$383$65,51381 claims
Boehringer IngelheimJardiance$96$55,07639 claims
Novo NordiskOzempic$174$36,89827 claims
PfizerEliquis$375$14,98615 claims
GSKTrelegy Ellipta$160$13,41320 claims
Johnson & JohnsonXarelto$83$11,57111 claims
AbbVieNamzaric, Synthroid$528$10,75655 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Lexington

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →